Encouraging Diversity in Clinical Trial Patients and NIDDK Staff | Advancing Health Through Research

As NIDDK celebrates its 70th anniversary, NIDDK Director Dr. Griffin P. Rodgers discusses the importance of diversity and inclusion in the Institute, both in clinical trials and amongst early and established scientists.

For more information, visit https://www.niddk.nih.gov/about-niddk...

---

Transcript:

DR. RODGERS: It was important that we consider in both the clinical trials and in both our early scientists and our established scientists that we made sure that we were an institute that was diverse and inclusive, particularly given the kinds of diseases that we were responsible for, as they disproportionately affect women and certain under-represented groups. We wanted to make sure that not only did our patient population that we recruited for our clinical trials reflected that diversity, but also the individuals who would actually be performing those studies. Our principal investigators and their supported staff also felt that NIDDK was a welcome home for them as well.